Should Drug Approval Decisions Consider Cost?

Article

A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.

A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.

J.PMorgan Chase estimated that global sales of this drug could teach $1.6 billion next year and $4.2 billion by 2020. That's a lot of money for a medication that some members of an FDA advisory committee believed had modest effectiveness.

This drug’s hefty price tag raises a few questions, including:

  • How long can our health care system sustain high prices for drug that only benefit a small number of patients?
  • Will some type of drug rationing result from the high costs?
  • Will there be legislation that requires drug approvals based on cost effectiveness?

What do you think?

Recent Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.